Mat serves as the vice president of data science at Jazz Pharmaceuticals, a global biopharmaceutical company. He oversees a team of 120 employees across all aspects of drug development including pharmacoepidemiology, clinical biostatistics, medical affairs statistics, bioinformatics, real world evidence, and integrated data analytics and statistical programming. Prior to Jazz, Mat was at Teva Pharmaceuticals providing statistical and biometrics leadership. He is a quantitative leader with a passion for ensuring that data scientists play a key role in the drug development lifecycle to provide innovative, best in class experimental design and interpretation to accurately and efficiently make safe and effective medicines available to patients in need.
